Journal of Virology, November 1998, p. 9025-9033, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Clinical Laboratory,
Received 28 May 1998/Accepted 13 July 1998
Human immunodeficiency virus infection is characterized by a
progressive decline in the number of peripheral blood CD4+
T lymphocytes, which finally leads to AIDS. This T-cell decline correlates with the degree of in vitro-induced lymphocyte apoptosis. However, such a correlation has not yet been described in feline AIDS,
caused by feline immunodeficiency virus (FIV) infection. We therefore
investigated the intensity of in vitro-induced apoptosis in peripheral
blood lymphocytes from cats experimentally infected with a Swiss
isolate of FIV for 1 year and for 6 years and from a number of
long-term FIV-infected cats which were coinfected with feline leukemia
virus. Purified peripheral blood lymphocytes were either cultured
overnight under nonstimulating conditions or stimulated with
phytohemagglutinin and interleukin-2 for 60 h. Under stimulating
conditions, the isolates from the infected cats showed significantly
higher relative counts of apoptotic cells than did those from
noninfected controls (1-year-infected cats, P = 0.01;
6-year-infected cats, P = 0.006). The frequency of in
vitro-induced apoptosis was inversely correlated with the CD4+ cell count (P = 0.002), bright
CD8+ cell count (P = 0.009), and CD4/CD8
ratio (P = 0.01) and directly correlated with the
percentage of bright major histocompatibility complex class II-positive
peripheral blood lymphocytes (P = 0.004). However, we
found no correlation between in vitro-induced apoptosis and the viral
load in serum samples. Coinfection with feline leukemia virus enhanced
the degree of in vitro-induced apoptosis compared with that in FIV
monoinfected cats. We concluded that the degree of in vitro-induced
apoptosis was closely related to FIV-mediated T-cell depletion and
lymphocyte activation and could be used as an additional marker for
disease progression in FIV infection.
*
Corresponding author. Mailing address: Clinical
Laboratory, Department of Internal Veterinary Medicine, University of
Zurich, Wintherthurer Str. 260, CH-8057 Zurich, Switzerland. Phone:
41-1-6358312. Fax: 41-1-6358906. E-mail:
hanslutz{at}vetklinik.unizh.ch.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|